Increased levels of biglycan in endometriomas and peritoneal fluid samples from ovarian endometriosis patients

Gynecological Endocrinology

Volumn 30, Issue 7, 2014, Pages 520-524

  Kocbek, Vida ^a   Hevir Kene, Neli ^a   Bersinger, Nick A ^b   Mueller, Michael D ^b   Rižner, Tea Lanišnik ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Benign ovarian cysts; Biomarker; ELISA; Western blotting

Indexed keywords

BIGLYCAN;

ARTICLE; BENIGN OVARIAN CYST; CONTROLLED STUDY; CURETTAGE; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTOPIC ENDOMETRIUM; FEMALE; GLYCOSYLATION; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; OVARY CYST; OVARY DISEASE; OVARY ENDOMETRIOSIS; PATHOGENESIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TISSUE LEVEL; WESTERN BLOTTING; ASCITES FLUID; BLOOD; CASE CONTROL STUDY; METABOLISM;

ASCITIC FLUID; BIGLYCAN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; OVARIAN CYSTS;

EID: 84903193359     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.898055     Document Type: Article

References (22)

1. Signorello LB, Harlow BL, Cramer DW, et al. Epidemiologic determinants of endometriosis: a hospital-based case-control study. Ann Epidemiol 1997;7: 267-741.
2. Goldman MB, Cramer DW. The epidemiology of endometriosis. Prog Clin Biol Res 1990;323: 15-31.
3. Sinaii N, Plumb K, Cotton L, et al. Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertil Steril 2008;89: 538-45.
4. Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011;118: 691-705.
5. Halme J, Hammond MG, Hulka JF, et al. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64: 151-4.
6. Witz CA, Thomas MR, Montoya-Rodriguez IA, et al. Shortterm culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium. Fertil Steril 2001; 75: 385-90.
7. Winterhager E, Fazleabas A, Hillier S. Endometriosis: science and sense. Mol Hum Reprod 2009;15:575.
8. May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010;16: 651-74.
9. Vouk K, Smuc T, Guggenberger C, et al. Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis. J Steroid Biochem Mol Biol 2011;125: 231-42.
10. Kresse H, Hausser H, Schonherr E. Small proteoglycans. Experientia 1993;49: 403-16.
11. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 1989;264: 4571-6.
12. Schaefer L, Iozzo RV. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 2008;283: 21305-9.
13. Neame PJ, Choi HU, Rosenberg LC. The isolation and primary structure of a 22-kDa extracellular matrix protein from bovine skin. J Biol Chem 1989;264: 5474-9.
14. Roughley PJ, White RJ, Magny MC, et al. Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J 1993;295: 421-6.
15. Schonherr E, Beavan LA, Hausser H, et al. Differences in decorin expression by papillary and reticular fibroblasts in vivo and in vitro. Biochem J 1993;290: 893-9.
16. Flannery CR. Usurped SLRPs novel arthritis biomarkers exposed by catabolism of small leucine-rich proteoglycans? Arthritis Res Therapy 2006;8:106.
17. Iozzo RV, Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 2010;277: 3864-75.
18. Schaefer L, Babelova A, et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 2005;115: 2223-33.
19. Kitaya K, Yasuo T. Dermatan sulfate proteoglycan biglycan as a potential selectin L/CD44 ligand involved in selective recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J Leukocyte Biol 2009;85: 391-400.
20. Jansen E, Laven JS, Dommerholt HB, et al. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol 2004;18: 3050-63.
21. Oksjoki S, Sallinen S, Vuorio E, Anttila L. Cyclic expression of mRNA transcripts for connective tissue components in the mouse ovary. Mol Hum Reprod 1999;5: 803-8.
22. Babelova A, Moreth K, Tsalastra-Greul W, et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009;284: 24035-48.